Surrozen SRZN
NASDAQ SRZN
$29.60 -0.40 (-1.32%)
As of: Oct 2, 2026 · 1:56 PM EDT

Surrozen (SRZN) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Surrozen's Depreciation & Amortization (CF) came in at $51,000 for Q2 2026, down 62.8% from $137,000 a year earlier and down 21.5% from the prior quarter.

Analysis

Surrozen (SRZN) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Surrozen reported Depreciation & Amortization (CF) of $222,000, down 79.7% year-over-year; for FY2025, it was $537,000, down 62.8% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last four years, with a five-year compound annual growth rate of -22.6% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $1.44 million in FY2024 (-24.5%), $1.91 million in FY2023 (-4.5%), $2 million in FY2022 (-4.8%) and $2.1 million in FY2021 (+8.4%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $45,000 (Q4 2025) to $572,000 (Q4 2021).
  • Year-over-year, Depreciation & Amortization (CF) has declined for 11 consecutive quarters, with an average decline of 57.0% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2021 (growth of 22.0%), and the weakest in Q4 2025 (a decline of 86.0%).
  • Business Quant data shows SRZN's Depreciation & Amortization (CF) at $65,000 (Q1 2026), $45,000 (Q4 2025) and $61,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Surrozen 378.24 Mn 378.24 Mn - 51,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51,000.00
Mar 31, 2026 65,000.00
Dec 31, 2025 45,000.00
Sep 30, 2025 61,000.00
Jun 30, 2025 137,000.00
Mar 31, 2025 294,000.00
Dec 31, 2024 322,000.00
Sep 30, 2024 342,000.00
Jun 30, 2024 386,000.00
Mar 31, 2024 392,000.00
Dec 31, 2023 451,000.00
Sep 30, 2023 483,000.00
Jun 30, 2023 495,000.00
Mar 31, 2023 482,000.00
Dec 31, 2022 523,000.00
Sep 30, 2022 470,000.00
Jun 30, 2022 473,000.00
Mar 31, 2022 534,000.00
Dec 31, 2021 572,000.00
Sep 30, 2021 525,000.00
API Access

Surrozen Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SRZN&period=max&api_key=YOUR_API_KEY